FGF23 and hyperphosphatemia: Our analysis showed that hypocalcemia, hyperphosphatemia, hyperparathyroidism, vitamin D and klotho deficiency, increased concentration of FGF-23, and abnormal bone mineralization and turnover contribute to the development of osteoporosis in patients with CKD [5,9].